Loading clinical trials...
Loading clinical trials...
We aimed to find out whether the tonsils and nasal tissues of pediatric patients are the main factors that protects the children's immune system against COVID-19 infection.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Selcuk University
NCT05398185 · HIV Infections, Acquired Immune Deficiency Syndrome, and more
NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
NCT06326983 · Tonsillitis, Post-operative Nausea and Vomiting (PONV), and more
NCT06370208 · Streptococcus Pyogenes Pharyngotonsillitis
NCT06576830 · Pain, Postoperative, Tonsillar Hypertrophy, and more
Selcuk University
Konya, Selcuklu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions